Lactobacillus Fermentum for Respiratory Health

Research suggests that certain probiotic consortia containing Lactobacillus fermentum may support antiviral immune responses relevant to respiratory health, with one preclinical study in ferrets and human immune cell cultures indicating that such probiotics can reduce viral loads and stimulate immune gene activity associated with defense against SARS-CoV-2. The available evidence comes from early-stage animal and in vitro research rather than human clinical trials, which limits the conclusions that can be drawn about real-world effectiveness in people. The second study included in this review examined gut microbiome patterns related to Clostridioides difficile and does not bear meaningfully on respiratory outcomes, underscoring how limited and indirect the current evidence base is for this specific application. Overall, while preliminary findings are intriguing, researchers themselves have called for controlled human trials before stronger conclusions about Lactobacillus fermentum and respiratory health can be made.